Open this article in Dearbloggers App
Market Research Future published a research report on I Endometrial Cancer Market Research Report – Forecast to 2023.Report gives a clear picture of current market scenario which includes past and estimated future market size
The abnormal growth of endometrium cells in the uterus is termed as endometrial cancer which is also known as uterine cancer. Endometrial cancer is diagnosed at an early stage as women experience abnormal vaginal bleeding. It is reported that endometrial cancer is the sixth most common cancer in women all over the world. The endometrial cancer market is expected to witness a tremendous growth owing to the rising prevalence of endometrial cancer. Other key factors such as the growing obesity among women, increase in menopausal hormone therapy, change in sedentary lifestyle, socioeconomic factors, growing consumption of unhealthy diet, increasing occurrence of Polycystic Ovarian Syndrome (PCOS), and increasing prevalence of breast or ovarian tumor are contributing towards the growth of the market. Diabetes is another risk factor that leads to the development of endometrial cancer. According to the American Cancer Society, endometrial cancer is four times common in diabetic women than in normal women. Such factors contribute to endometrial cancer among women.
Endometrial Cancer Market Overview
The global Endometrial Cancer Market is expecting a robust CAGR and a strong market presence during the forecast period (2018-2023), in an all-inclusive study asserts Market Research Future (MRFR). Endometrial cancer is also known as uterine cancer and is the sixth most common cancer in women across the world. The daunting number speaks for itself and promotes the factors that ensure the market growth for endometrial cancer.
Drivers and Restraints:
Urbanization across the world is experiencing an express speed growth rate owing to which the population is undergoing remarkable lifestyle change. A sedentary lifestyle has become the norm for many, and growing obesity among women is resulting in the rising number of endometrial cancer. Lack of nutritional elements in consumed food and other diseases such as polycystic ovarian syndrome (PCOS) and the ovarian tumor can trigger endometrial cancer.
The global endometrial cancer market can be segmented by diagnosis, treatment, and end-user.
By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy. Endometrial biopsy is very common as the confirmatory test for uterine cancer.
Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. The hysterectomy techniques category comprises open abdominal hysterectomy, total vaginal hysterectomy, total laparoscopic hysterectomy, and robotic hysterectomy. External radiation and internal radiation (brachytherapy) are part of radiation technology. The hormonal therapy consists progestins, tamoxifen, luteinizing hormone-releasing hormone agonists, and aromatase inhibitors. Chemotherapy can be further sub-segmented into paclitaxel, carboplatin, doxorubicin, and cisplatin and is also the most-used treatment method.
Get Global Endometrial Cancer Market Research Report, by Diagnosis (Pelvic Examination, Transvaginal Ultrasound, Endometrial Biopsy), Treatment (Hysterectomy, Radiation), End-User (Hospitals & Clinics, Ambulatory Surgical Centers) – Global Forecast Till 2023
The prominent players involved in the market are Pfizer Inc., General Electric Company, Koninklijke Philips N.V., LUPIN, PHYTON, Bayer AG, Celgene Corporation, Johnson & Johnson, CooperSurgical Inc., LiNA Medical USA, Conceptus Inc., Hologic Inc., Karl Storz GmbH & Co. Kg, and Boston Scientific Corporation.
About Market Research Future:
MRFR team has supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country-level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with the technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Market Research Future
+1 646 845 9312
Michael Owens serves as the marketing advisor of Head45 in Cardiff Bay. He is a specialist in customer experience and an expert brand strategist who is keen to take on challenges that will help the business expand. Michael puts his creative energy into penning posts that are both interesting and useful for the most popular blogging sites.